SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FAINARDI, Enrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.325
EU - Europa 3.263
AS - Asia 3.213
SA - Sud America 559
AF - Africa 59
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 9
Totale 17.442
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.268
SG - Singapore 1.366
CN - Cina 1.184
DE - Germania 615
UA - Ucraina 615
IT - Italia 589
BR - Brasile 517
TR - Turchia 373
GB - Regno Unito 365
FI - Finlandia 273
PL - Polonia 261
SE - Svezia 172
RU - Federazione Russa 93
HK - Hong Kong 63
FR - Francia 60
ID - Indonesia 60
BE - Belgio 55
AT - Austria 42
CA - Canada 39
CZ - Repubblica Ceca 33
VN - Vietnam 27
NL - Olanda 25
ZA - Sudafrica 25
IN - India 24
BD - Bangladesh 18
IR - Iran 17
AR - Argentina 15
IQ - Iraq 13
JP - Giappone 12
LT - Lituania 11
MA - Marocco 10
PK - Pakistan 9
UZ - Uzbekistan 9
AU - Australia 8
MX - Messico 8
A2 - ???statistics.table.value.countryCode.A2??? 7
CO - Colombia 7
ES - Italia 7
RO - Romania 7
EU - Europa 6
KE - Kenya 6
PT - Portogallo 6
SA - Arabia Saudita 6
UY - Uruguay 6
BG - Bulgaria 5
EC - Ecuador 5
IE - Irlanda 5
KR - Corea 5
CH - Svizzera 4
EG - Egitto 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
DZ - Algeria 3
HN - Honduras 3
KZ - Kazakistan 3
NG - Nigeria 3
NP - Nepal 3
PH - Filippine 3
SI - Slovenia 3
AL - Albania 2
AO - Angola 2
CL - Cile 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
JM - Giamaica 2
LU - Lussemburgo 2
MD - Moldavia 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BH - Bahrain 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
MG - Madagascar 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
SN - Senegal 1
SV - El Salvador 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 17.442
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.320
Fairfield 1.078
Chandler 760
Houston 714
Jacksonville 668
Ashburn 639
Singapore 617
Santa Clara 589
Ann Arbor 558
Wilmington 390
Seattle 374
Cambridge 357
Beijing 277
Warsaw 251
Izmir 233
Nanjing 218
Ferrara 190
Princeton 179
Munich 144
Milan 142
New York 134
Boardman 121
Shanghai 109
Los Angeles 97
San Diego 89
Addison 80
Dearborn 79
Helsinki 70
Nanchang 66
Hong Kong 63
Shenyang 63
Turku 63
Bremen 59
Brussels 55
Jakarta 55
Jiaxing 49
Hebei 46
São Paulo 44
Tianjin 43
Changsha 42
Norwalk 38
London 37
The Dalles 37
Falls Church 32
Vienna 31
Brno 29
San Mateo 28
Ningbo 26
Brooklyn 24
Jinan 24
Redwood City 23
Orange 22
Auburn Hills 21
San Francisco 21
Zhengzhou 21
Bologna 20
Falkenstein 19
Mountain View 18
Rio de Janeiro 18
Columbus 17
Kunming 17
Nuremberg 17
Stockholm 17
Toronto 17
Guangzhou 16
Moscow 16
Rome 16
Frankfurt am Main 15
Tappahannock 15
Boston 14
Dong Ket 14
Taizhou 14
Des Moines 13
Hefei 13
Verona 13
Washington 13
Atlanta 12
Chicago 12
Curitiba 12
Leawood 12
Belo Horizonte 11
Tokyo 11
Ardabil 10
Brasília 10
Düsseldorf 10
Kraków 9
Philadelphia 9
Tashkent 9
Charlotte 8
Hangzhou 8
Indiana 8
Ottawa 8
Recife 8
Secaucus 8
Ankara 7
Augusta 7
Kilburn 7
Ribeirão Preto 7
Cape Town 6
Guarulhos 6
Totale 12.086
Salva come PNG Salva come JPEG
Nome #
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 359
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 181
HLA-G Molecules in Autoimmune Diseases and Infections 179
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 177
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 176
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 166
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 166
Evaluation of acute perihematomal regional apparent diffusion coefficient abnormalities by diffusion-weighted imaging 165
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 161
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 156
Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 155
Chlamydia pneumoniaespecific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms 154
CT perfusion mapping of hemodynamic disturbances associated to acute spontaneous intracerebral hemorrhage 154
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 153
Awake surgery in low-grade gliomas harboring eloquent areas: 3-year mean follow-up 152
Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules 152
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 150
Emerging topics and new perspectives on HLA-G 149
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 148
Technical, Anatomical, and Functional Study after Removal of a Symptomatic Cavernous Angioma Located in Deep Wernicke's Territories with Cortico-Subcortical Awake Mapping. 147
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 147
Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients 147
Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up 146
Cerebrospinal fluid analysis and the determination of oligoclonal bands 144
Survival prediction in high-grade gliomas using CT perfusion imaging 142
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients 140
Leptin/adiponectin ratio predicts post-stroke neurological outcome 140
Assessment of HIV-intrathecal humoral immune response in AIDS-related neurological disorders 138
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation. 137
Alterazioni liquorali nella sindrome di Guillain-Barrè: Utilità nella diagnosi e nel monitoraggio della malattia. 136
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 134
Study of Soluble HLA-G in Congenital Human Cytomegalovirus Infection 133
Spinal anterior epidural hematoma in an elderly man with unrecognized lupic anticoagulant taking warfarin 131
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 131
Spontaneous and idiopathic chronic spinal epidural hematoma: two case reports and review of the literature 130
The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS 130
A new developed culture method efficiently supports the growth of Chamydia pneumoniae in PBMC and CSF samples from patients with Multiple Sclerosis 128
A Further Evidence Of Pathogenic Role Of Chlamydia Pneumoniae In Multiple Sclerosis 127
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 125
Hyperfusion Syndrome Secondary to Carotid Endovascular Rivascularization: a case report 123
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 122
Neurofilament ELISA validation 122
null 121
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 120
Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings 120
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 118
Temporal changes in CT perfusion values before and after cranioplasty in patients without symptoms related to external decompression: A pilot study 118
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 117
New insights into HLA-G and inflammatory diseases 116
Some basic aspects of HLA-G biology. 116
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 116
Hyperperfusion syndrome secondary to carotid endovascular rivascularization: a case report 116
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 115
Recent advances in our understanding of HLA-G biology: Lessons from a wide spectrum of human diseases 115
The incidence of Guillain-Barrè syndrome in Ferrara, Italy: is the disease really increasing? 115
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS 113
DNA Sequences of Parachlamydia-like organisms in CSF of Patients with Neurological Disorders 112
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 112
Cerebrospinal fluid (CSF) Protein Immunoglobulin and cellular abnormalities in Acquired Immune Deficiency Syndrome (AIDS) 111
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 110
Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms 110
Exogenous gangliosides and Guillain-Barre syndrome. An observational study in the Local Health District of Ferrara, Italy 110
null 110
null 109
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 108
Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage. 107
Antigeni solubili di classe I classici e non classici (sHLA G) nei fluidi cerebrospinali della sclerosi multipla 106
Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients 106
Impaired Cerebral Venous Haemodynamics In Multiple Sclerosis Patients 105
null 104
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 104
The role of [123I]-FP-CIT SPECT in the diagnosis and clinical menagement of Parkinson's disease 104
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 103
25 hydroxyvitamin D in cerebrospinal fluid from patients with multiple sclerosis during relapse and remission 102
null 102
Altered miRNA expression in T regulatory cells in course of multipla sclerosis 100
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 100
Le catene leggere libere liquorale sclerosi multipla 99
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 98
null 97
null 97
null 96
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 96
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 96
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 96
Therapeutic plasma exchange for worsening relapsing remitting multiple sclerosis. A case report 94
Decreased serum PCSK9 levels after ischemic stroke predict worse outcomes 94
Inverse association between CSF levels of solubile HLA-G and Fas molecules in MS patients with no evidence of MRI disease activity. 92
Cerebrospinal fluid oligoclonal free light chain profiles in AIDS 91
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 91
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 91
null 90
Detection of Parachlamydialike organisms in patients with multiple sclerosis. 89
Significance of anti-Chlamydophila pneumoniae IgA and IgG determination in patients with acute and post-acute ischaemic stroke 88
null 88
Chlamydia pneumonia-specific CFS-restricted oligoclonal IgG bands are associated to a subset of patients with prosessive forms of multiple sclerosis. 87
null 87
Detection of Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response in a subset of patients with progressive forms of multiple sclerosis 87
Congruence between clinical diagnosis and DATSCAN imaging in 150 consecutive patients. 86
Cerebrospinal fluid free Kappa and Lambda lights chains in MS. A qualitative analysis 86
Totale 12.340
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.582
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 799
Totale 95.381
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.815 151 131 71 193 76 177 64 216 67 264 280 125
2021/20221.600 84 182 96 51 54 73 75 94 52 139 133 567
2022/20231.796 181 154 68 244 277 234 121 168 207 7 92 43
2023/20241.047 95 107 52 28 110 198 35 88 31 29 24 250
2024/20254.005 103 91 307 157 528 349 98 156 760 476 561 419
2025/2026417 417 0 0 0 0 0 0 0 0 0 0 0
Totale 17.729